Transcat

Transcat, Inc. engages in provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Transcat reports 12% revenue growth and eyes European expansion

Transcat, Inc. delivered strong financial performance in fiscal 2023, with notable revenue and EBITDA growth. The company's successful acquisitions and focus on margin expansion position them for continued success. However, they face challenges related to CapEx and income tax rates. Opportunities lie in geographical expansion, organic growth, and strategic M&A.

Transcat reports strong Q1 2024 earnings, eyes NEXA expansion

Transcat's Q1 2024 earnings call showcased robust financial performance, a strong balance sheet, and strategic acquisitions aimed at driving future growth. While the company faces challenges in maintaining projected organic growth and executing its acquisition strategy, the NEXA business presents significant opportunities for expansion and value creation.

Transcat excels in Q3, eyes growth in aviation and Ireland

Transcat's Q3 performance reflects strong revenue and margin growth, driven by organic and acquisition strategies.
The company's focus on continuous improvement, automation, and acquisitions positions it for sustainable margin enhancement and market expansion.
While challenges exist in maintaining growth momentum and navigating competitive markets, Transcat's positive outlook and strategic initiatives bode well for future success.

Transcat reports robust fiscal 2023 performance and optimistic outlook

Transcat's fiscal 2023 performance showcased revenue growth, margin expansion, and successful acquisitions, setting a strong foundation for future growth.
The company's focus on leadership development and strategic planning bodes well for sustained success in the coming years.
With a positive outlook for fiscal 2024 and a clear emphasis on organic growth and margin expansion, Transcat is poised for continued success.

Transcat reports strong Q2 earnings, eyes growth through acquisitions

Transcat's Q2 2024 earnings call highlighted robust financial performance, strategic acquisitions, and a focus on operational efficiency and growth.
Despite challenges such as nonrecurring charges and investment needs, the company's strong balance sheet and cash flow improvements bode well for future prospects.
With a clear roadmap for organic growth, margin expansion, and leveraging acquisitions, Transcat is poised to capitalize on market opportunities and drive sustainable value creation.

Transcat reports solid Q2 earnings, eyes growth amidst challenges

Transcat's Q2 2025 performance reflects revenue growth, net income improvement, and financial stability, despite short-term challenges.
The company's focus on operational efficiency and inventory management underpins consistent cash flow and a strong total net cash position.
Challenges from NEXA issues and external factors highlight the need for strategic adjustments to drive future growth and profitability.
Opportunities lie in addressing operational challenges, capitalizing on market demand, and optimizing margins for sustained performance.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Transcat, Inc. engages in the provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade tests, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.

H.C. Wainwright analyst Scott Buck  raised the price target on Transcat, Inc. (NASDAQ:TRNS) to $105 (an upside of 20.7%) from $95 and maintained a Buy rating on the shares. Buck says increasing volatility "may leave investors looking for a safe space," and Transcat's visibility warrants a premium valuation.

H.C. Wainwright Sees 21% Upside In Transcat

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today announced that Forbes has named it one of America's top 100 small companies for 2022 in its recently released list. Transcat was ranked 75th on the list with a 52-week return of 181.6 percent.

Transcat named one of America's Best Small Companies by Forbes

Transcat, Inc. (TRNS) could produce exceptional returns because of its solid growth attributes.

Is Transcat, Inc. (TRNS) a Solid Growth Stock? 3 Reasons to Think " Yes "

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. to Present at Sidoti Virtual Micro Cap Investor Conference

Transcat, Inc. to Present at Sidoti Virtual Micro Cap Investor Conference

Transcat, Inc. (TRNS) CEO Lee Rudow on Q2 2022 Results - Earnings Call Transcript

Transcat, Inc. (TRNS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Transcat, Inc. (TRNS) Hits 52-Week High, Can the Run Continue?

Transcat, Inc. (TRNS) delivered earnings and revenue surprises of 8.11% and 6.75%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Transcat, Inc. (TRNS) Q2 Earnings and Revenues Surpass Estimates

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its second quarter ended September 25, 2021 (the “second quarter”) of fiscal year 2022, which ends March 26, 2022 (“fiscal 2022”). Results include the previously

Transcat Reports Second Quarter Adjusted EBITDA Increase of 35.5% to $7.1 Million on Strong Revenue Growth and Gross Margin Expansion

Transcat (NASDAQ:TRNS) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement.

Transcat Earnings Preview

Allied Motion Technologies

Watts Water Technologies

Supply chain disruptions resulting in higher material costs make prospects gloomy for the Zacks Instruments - Control industry. Nonetheless, the growing importance of energy efficiency and adoption of industrial automat should drive Watts Water (WTS), Allied Motion (AMOT), and Transcat (TRNS).

3 Instrument Stocks That Hold Promise Amid Industry Challenges

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year 2022 results after the close of financial markets on Tuesday, November 2, 2021. The Company will host a conference call and webcast to r

Transcat Announces Second Quarter Fiscal Year 2022 Conference Call and Webcast

Sensata Technologies Hld

ST vs. TRNS: Which Stock Is the Better Value Option?

ST or TRNS: Which Is the Better Value Stock Right Now?

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (NASDAQ: TRNS), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that Lee D. Rudow, Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference, taking place virtually September 13-15, 2021. The p

Transcat, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Transcat, Inc. (NASDAQ: TRNS) has purchased  Cal Opex Limited (d/b/a NEXA Enterprise Asset Management) for $22.5 million, consisting of $20.25 million in cash $2.25 million in common stock. Additionally, there are potential earn-out payments of up to $7.5 million over the next four years based upon NEXA achieving specific annual revenue and EBITDA goals.

Transcat Acquires NEXA Enterprise Asset Management For $22.5M

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held Cal Opex Limited (d/b/a NEXA Enterprise Asset Management), effective August 31, 2021. The purchase price of $22.5 million c

Transcat Expands Life Science Service Capabilities and Geographic Reach into Ireland with Acquisition of NEXA Enterprise Asset Management

ST vs. TRNS: Which Stock Should Value Investors Buy Now?

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

Transcat, Inc. (TRNS) Recently Broke Out Above the 20-Day Moving Average

ArcBest

Daseke

Tupperware

TRNS, ARCB, TUP, and DSKE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 20, 2021

Top Ranked Momentum Stocks to Buy for August 20th

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (NASDAQ: TRNS), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that Lee D. Rudow, Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present and be available for investor meetings at the Oppenheimer Technology, Internet and Communications Virtual Conference

Transcat, Inc. to Present at Oppenheimer Technology, Internet, and Communications Virtual Conference

Transcat, Inc. (TRNS) possesses solid growth attributes, which could help it handily outperform the market.

Looking for a Growth Stock? 3 Reasons Why Transcat, Inc. (TRNS) is a Solid Choice

Transcat, Inc. (TRNS) Soars to 52-Week High, Time to Cash Out?

Transcat, Inc. (TRNS) CEO Lee Rudow on Q1 2022 Results - Earnings Call Transcript

Transcat, Inc. (TRNS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Transcat, Inc. (TRNS) Moves to Buy: Rationale Behind the Upgrade

Shares of Transcat (NASDAQ:TRNS) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 345.45% year over year to $0.49, which beat the estimate of $0.25.

News for Transcat Stock (TRNS)